Moreover, FBXO45 inhibited cancer development and metastasis by targeting EMT-inducing transcription factors, including SNAI1/2, TWIST1/2, and ZEB1/2, in various cancer cells36,57. This evidence concerns the gene FBXO45 and cancer.